Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lutein, Bilberry, Ginkgo In Juices Not Authorized, FDA Tells Smucker

This article was originally published in The Tan Sheet

Executive Summary

Smucker Quality Beverages' Simply Nutritious Visionade contains herbal ingredients that have not been previously sanctioned or generally recognized as safe in juices, FDA says in a June 8 warning letter. The agency takes issue with the inclusion of lutein, bilberry extract and ginkgo in Visionade, marketed under the R.W. Knudsen Family of beverages.

You may also be interested in...



Echinacea Nutrient Content Claims Misbrand Juice Products - FDA

Fresh Samantha Super Juice with Echinacea makes unauthorized nutrient content claims that misbrand the product, FDA says in a June 4 warning letter.

Red Yeast Rice Enforcement Actions, Product Withdrawals Underway

FDA is stepping up enforcement activity against red yeast rice product manufacturers and marketers in the wake of a Utah federal judge's recent decision finding the ingredient to be a drug, not a dietary supplement.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092721

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel